Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China flag China · Delayed Price · Currency is CNY
26.46
+0.44 (1.69%)
Oct 23, 2026, 3:00 PM CST

SHA:600976 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
217.68113.71163.17305.12219.33301.66
Short-Term Investments
216.45136.51----
Trading Asset Securities
968.56954.14954.19694.46641.38538.63
Cash & Short-Term Investments
1,4031,2041,117999.58860.71840.28
Cash Growth
24.91%7.79%11.78%16.13%2.43%45.64%
Accounts Receivable
954.581,040957.561,150868.66674.6
Other Receivables
45.56123.825.7631.4349.6421.43
Receivables
1,0001,164983.331,181918.29696.03
Inventory
292.48286.57354.31450.85362.88222.6
Other Current Assets
103.1294.89146.43134.06162.85104.5
Total Current Assets
2,7982,7502,6012,7662,3051,863
Property, Plant & Equipment
652.66698.07595.59450.7417.65396.65
Long-Term Investments
740.72722.3772.18650.42444.94326.85
Goodwill
0.210.210.210.210.210.21
Other Intangible Assets
25.5927.5328.1928.8731.1632.98
Long-Term Deferred Tax Assets
175.57180.34129.49139.44117.27118.33
Long-Term Deferred Charges
135.28136.33130.78111.2791.6687.64
Other Long-Term Assets
10.3712.1619.7421.1432.5630.01
Total Assets
4,5394,5274,2784,1683,4402,856

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
627.1642.52742.22782.91611.06374.92
Accrued Expenses
33.14716.3574.78724.73620.32592.57
Short-Term Debt
2055.05140.979.4522.5245
Current Portion of Long-Term Debt
6.920.37----
Current Portion of Leases
-5.626.395.127.346.1
Current Income Taxes Payable
126.81104.0552.7466.2349.6871.75
Current Unearned Revenue
32.8636.1961.4341.1982.5237.04
Other Current Liabilities
809.47175.74166.66157.31140.25191.85
Total Current Liabilities
1,6561,7361,7451,8571,5341,319
Long-Term Debt
33.8434.034---
Long-Term Leases
32.2231.0324.4330.2923.4820.37
Long-Term Unearned Revenue
36.244.4146.5518.6112.1827.72
Long-Term Deferred Tax Liabilities
4.724.87.25.625.970.84
Total Liabilities
1,7631,8501,8271,9111,5751,368

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
153.4153.4153.4153.4153.4153.4
Additional Paid-In Capital
522.73522.73523.42520.68509.17421.5
Retained Earnings
2,0811,9801,7581,5801,212931.06
Treasury Stock
----6.76-14.99-25.08
Total Common Equity
2,7572,6562,4352,2481,8601,481
Minority Interest
18.9120.415.038.784.997.04
Shareholders' Equity
2,7762,6772,4502,2561,8651,488
Total Liabilities & Equity
4,5394,5274,2784,1683,4402,856

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
92.98126.1175.71114.8653.3471.48
Net Cash (Debt)
1,3101,078941.65884.72807.37768.81
Net Cash Growth
30.45%14.51%6.44%9.58%5.02%38.07%
Net Cash Per Share
8.637.106.195.795.305.06
Filing Date Shares Outstanding
153.4153.4153.4153.82152.78151.97
Total Common Shares Outstanding
153.4153.4153.4153.82152.78151.97
Working Capital
1,1421,014856.33908.95771.06544.18
Book Value Per Share
17.9717.3215.8814.6112.179.74
Tangible Book Value
2,7312,6292,4072,2191,8291,448
Tangible Book Value Per Share
17.8017.1415.6914.4211.979.53
Buildings
-409.52287.12284.12289.38298.05
Machinery
-485.88314.22312.36301.9251.25
Construction In Progress
-40.17206.6841.4817.1916.73